Peregrine Pharmaceuticals Inc. (PPHM) Misses Q3 EPS by 3c
Tweet Send to a FriendGet Alerts PPHM Hot Sheet
Price: $1.83 --0%
EPS Growth %: +69.2%
Financial Fact:
Total revenues: 7.04M
Today's EPS Names:
MGT, RXN, KID, More
EPS Growth %: +69.2%
Financial Fact:
Total revenues: 7.04M
Today's EPS Names:
MGT, RXN, KID, More
Trade PPHM Now!
Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) reported Q3 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $2.88 million versus the consensus estimate of $5.26 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Peregrine Pharma (PPHM) to resume trading at 9:15am ET
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
- China TechFaith (CNTF) Swings to Q1 Profitl; Guides Q2 Sales
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
